Health Care: Drugs

PDL BioPharma Inc (PDLI: NASDAQ)

$2.54 n/a | n/a%
06/23/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 213.90M 554.25M 533.21M 437.28M
Cost of Sales 4.07M 0.00 0.00 0.00
Gross Operating Profit 209.83M 554.25M 533.21M 437.28M
Selling, General, and Administrative Expenses 40.33M 36.09M 34.91M 29.75M
Research & Development 3.82M 0.00 0.00 0.00
Operating Income before D & A (EBITDA) 165.68M 518.16M 498.29M 407.53M
Depreciation & Amortization 22.05M 13.00M 18.56M 13.72M
Interest Income 30.99M 36.57M 48.34M 242.00K
Other Income - Net -56.99M 2.47M -6.14M 18.98M
Special Income / Charges 3.54M 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 117.61M 544.19M 521.92M 413.02M
Interest Expense 18.27M 27.06M 39.21M 24.87M
Pre-Tax Income 99.34M 517.13M 482.71M 388.15M
Income Taxes 45.71M 197.34M 179.03M 137.35M
Minority Interest 53.00K 0.00 0.00 0.00
Net Income From Continuing Operations 63.66M 332.80M 322.24M 264.53M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 63.66M 332.80M 322.24M 264.53M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 63.61M 332.80M 322.24M 264.53M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
63.68M 332.80M 322.24M 264.53M
Preferred Dividends
Net Income Available To Common 63.66M 332.80M 322.24M 264.53M
Basic EPS from Continuing Ops. 0.39 2.04 2.04 1.89
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 0.39 2.04 2.04 1.89
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.39 2.04 2.04 1.89
Basic Normalized Net Income/Share 0.39 2.04 2.04 1.89
EPS fr Continuing Ops. 0.39 2.03 1.86 1.66
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 0.39 2.03 1.86 1.66
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 0.39 2.03 1.86 1.66
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.39 2.03 1.86 1.66
Dividends Paid per Share 0.10 0.60 0.60 0.60

Portfolios with PDLI

Latest PDLI Headlines from TheStreet

More Financial News for PDLI

Press Releases for PDLI

See All Press Releases

Partner Headlines for PDLI

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter